Cut the Chat
Life Science Insider Podcast
Catch all the latest Cut the Chat Life Science Insider Podcast episodes. Join Seuss+ CEOs Kieran and Sabine as they facilitate conversations worth having with Life Science industry leaders.
Welcome to Cut the Chat – Life Science Insider
An informative podcast series designed quite literally to cut the unnecessary talk and get straight to the point and heart of many life science and biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
We’ll facilitate the conversations you’ve been dying to hear and tackle the real crux of our industry’s challenges while addressing the subjects of what we can do as life science leaders to be more successful in a shorter period of time, conversations that might actually help each other when we dare to open up.
Sabine Hutchison
Co-Host
CEO and Seuss+ Co-founder, former chemist turned entrepreneur, Sabine, helps life science companies and leaders create the right business narrative, get stakeholder buy-in, and navigate growth to reach their full potential to make an impact in their fields.
Kieran Canisius
Co-Host
CEO and Seuss+ co-founder Kieran brings together regulatory, growth, clinical, and subject matter experts at the forefront of their life science specialties to energetically support clients in overcoming their challenges and finding new strategies for success.
Latest Episode
Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
In the third episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by Victoria Bangieva from the Digital Medicine Society (DiMe) and our very own Director of Digital Innovation, Lauren Alani, as they share some incredible insights on a groundbreaking initiative, Building the Business Case for Digital Endpoints.
Season 2, Episode 3 | 35 min
S2 E2 – Navigating the Commercialization Journey: Insights from Science to Market
Dive into the crucial aspects of biotech commercialization with Kirsten Detrick on Season 2, Episode 2 of the Cut The Chat Podcast. Learn why early commercialization strategies matter and discover key insights from a seasoned biotech executive.
S2 E1 – Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions
Tune in to Cut The Chat’s Season 2, Episode 1 as Seuss+ CEO Sabine Hutchison explores with Stephanie Oestreich of MIF the intersections of investment, scientific breakthroughs, and the quest for a Myeloma cure. Dive into a conversation about the challenges and triumphs of specialty funds and the impact of strategic investments on clinical trials.